Health Intervention and Technology Assessment Program, Department of Health, Ministry of Public Health, Muang, Nonthaburi, Thailand.
Int J Technol Assess Health Care. 2019;35(6):467-473. doi: 10.1017/S0266462319000321. Epub 2019 Jun 13.
To explore health technology assessment (HTA) in Thailand focusing on its institutionalization, key elements for HTA introduction, and HTA contribution to policy.
A review of literature covered a wide range of topics, including the institutionalization of HTA, elements of HTA introduction, and the role of HTA in policy decision making in Thai context. Additional information from the authors' involvement in the policy decision-making process in Thailand was also considered.
HTA institutionalization comprises processes of introducing HTA, including evidence generation and use in policymaking, building capacity of HTA practitioners, organizations, system infrastructure, and collaborations. In Thailand, HTA has been formally integrated into coverage decisions, including in the development of the National List of Essential Medicines and the Universal Health Coverage Scheme benefits package. Contributing factors included political will and leadership, capacity building on HTA-related disciplines, adequate resources, technical expertise, and data. Conversely, challenges faced included the absence of a governing body and strategic plan for HTA systems development, a lack of formal mechanisms for mobilizing financial support, an inadequate number of HTA researchers in nonprofit institutes, and the rise in advanced biotechnologies.
HTA plays an important role in evidence-based healthcare decision making. However, key elements of HTA institutionalization need to be strengthened, especially governance structure and policy for HTA systems development, building and retaining capacity of HTA practitioners to meet demand, addressing the challenges of complex and highly innovative health interventions. Lessons learned from the Thai experience may be used as guidance for HTA institutionalization in other developing countries.
探讨泰国的卫生技术评估(HTA),重点关注其制度化、引入 HTA 的关键要素以及 HTA 对政策的贡献。
文献综述涵盖了广泛的主题,包括 HTA 的制度化、引入 HTA 的要素以及 HTA 在泰国背景下政策决策中的作用。还考虑了作者在泰国政策决策过程中的参与所获得的额外信息。
HTA 的制度化包括引入 HTA 的过程,包括在决策中生成和使用证据,培养 HTA 从业者、组织、系统基础设施和合作的能力。在泰国,HTA 已正式纳入覆盖范围决策,包括国家基本药物清单和全民健康覆盖计划福利包的制定。促成因素包括政治意愿和领导力、与 HTA 相关学科的能力建设、充足的资源、技术专长和数据。相反,面临的挑战包括缺乏治理机构和 HTA 系统发展战略计划、缺乏调动财政支持的正式机制、非营利机构中 HTA 研究人员数量不足以及先进生物技术的兴起。
HTA 在循证医疗保健决策中发挥着重要作用。然而,HTA 制度化的关键要素需要加强,特别是治理结构和 HTA 系统发展政策,培养和保留满足需求的 HTA 从业者的能力,解决复杂和高度创新的卫生干预措施的挑战。从泰国经验中吸取的教训可作为其他发展中国家 HTA 制度化的指导。